Pacific Biosciences is reducing both headcount and spending across its DNA sequencing business, in the face of escalating global tariffs and threats to federal biomedical research grants. | Looking to ...

Illumina ranks as the largest player in genetic sequencing. Other top genetic sequencing companies include PacBio, 10X Genomics, and Oxford Nanopore Technologies. Key findings are powered by ...

PACB), also known as PacBio, both fell 10%, while Illumina (NASDAQ:ILMN) and Bio-Rad (BIO) shares fell 5% and 4%, ...

In a report released yesterday, Eve Burstein from Bernstein maintained a Buy rating on Pacific Biosciences (PACB – Research Report), with a ...

Let’s take a look at how Illumina (NASDAQ:ILMN) and the rest of the life sciences tools & services stocks fared in Q4. The life sciences tools and services sector supports the research ...

PacBio to cut jobs, lower spending over NIH ... Activist investor Keith Meister to join Illumina's board Illumina said on Tuesday activist investor Keith Meister would join the gene-sequencing ...

As it faces uncertainty in the research market at home and abroad, Illumina is making changes to its board of directors, bringing on an activist investor and installing a former FDA commissioner ...

Sergott covers the Healthcare sector, focusing on stocks such as Sotera Health, Illumina, and Waters. Currently, the analyst consensus on Pacific Biosciences is a Moderate Buy with an average price ...

Pacific Biosciences While Offloading Illumina And Amgen Cathie Wood-led Ark Invest made notable trades, buying IRDM, BEAM, PACB, ABSI and selling ILMN, RPTX, AMGN, VEEV.